Clinical trials
Diabetic clinical trials
Below are recruiting diabetic clinical trials, each written for real people, not researchers. We’re tracking 2,208 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06977230Recruiting
Arm-cuff protection before heart bypass in diabetes
This study tests whether a simple arm-cuff procedure done before heart bypass surgery can help protect the heart in people with type 2 diabetes. The goal is to see if this technique reduces complications during and after the operation.
MuğlaAges 45–85 - NCT06979440Recruiting
Berberine for diabetes with depression
This trial tests if berberine, a natural compound, can improve both blood sugar and mood in people who have type 2 diabetes and major depression. It aims to understand how berberine works at a molecular level.
Nantong, JiangsuAges 18–65 - NCT06981234RecruitingPhase 2
Acetazolamide for type 1 diabetes
This trial tests whether a medicine called acetazolamide (used for altitude sickness) can help people with type 1 diabetes. It compares how your body responds while on the drug versus a placebo, using a crossover design so everyone gets both treatments.
La Jolla, CaliforniaAges 18 years+ - NCT06983054RecruitingPhase 4
Salt, kidneys, and ertugliflozin in type 2 diabetes
This study tests if changing how much salt you eat affects how the drug ertugliflozin works in people with type 2 diabetes. You would take either the drug or a placebo (a dummy pill) for a short time while following a low- or high-salt diet, to see how your kidneys and blood vessels respond.
Denver, ColoradoAges 18–85 - NCT06984185Recruiting
Early detection of type 1 diabetes in children
This trial is looking for children with newly diagnosed type 1 diabetes to study how to detect the condition earlier. It focuses on kids who have already reached the stage where symptoms appear, to improve understanding of the disease.
Bron, RhôneAges 1–18 - NCT06985095Recruiting
Learning about healthy eating for diabetes with insulin use
This trial tests a program that teaches people with diabetes how to eat healthier to better control their blood sugar. It is for adults who use insulin and have high blood sugar levels.
Ho Chi Minh City, VietnamAges 18–70 - NCT06989008Recruiting
Improving diabetes care with wearable sensors
This study tests if wearing two devices (a continuous glucose monitor and a sports wristband) can help improve diabetes care. It focuses on people with type 2 diabetes who live in certain Chicago neighborhoods and are willing to use the devices.
Chicago, IllinoisAges 18–65 - NCT06989190Recruiting
Study of blood vessel damage in type 1 diabetes
This study looks at how type 1 diabetes affects small blood vessels, especially in the eyes, kidneys, and feet. It tests a special camera and other devices to see how severe the damage is, which may help doctors find better ways to treat complications early.
StockholmAges 18–60 - NCT06989723RecruitingPhase 4
Pioglitazone and empagliflozin for fatty liver in type 2 diabetes
This trial tests two diabetes pills (pioglitazone and empagliflozin) to see if they can reduce liver fat in people with type 2 diabetes and fatty liver disease. It may help if your diabetes is not well controlled and you have a fatty liver confirmed by a special ultrasound scan.
Seongnam-siAges 20 years+ - NCT06994403Recruiting
Pasta and blood sugar in type 1 diabetes
This study checks how eating a special carb-enriched pasta affects blood sugar in people with type 1 diabetes and compares it to healthy volunteers. It may help find better mealtime strategies for managing diabetes.
NaplesAges 18–50 - NCT06999356Recruiting
Salud Diabetes: Lifestyle Changes and Glucose Monitoring Study
This study tests if combining lifestyle coaching with a continuous glucose monitor (CGM) helps people with type 2 diabetes improve their blood sugar control. You'll track your glucose levels using a study device and see how daily habits affect them.
Santa Barbara, CaliforniaAges 18–89 - NCT07002125Recruiting
Whole body vibration therapy for type 2 diabetes
This study tests whether whole body vibration therapy can help people with type 2 diabetes manage their blood sugar better. It involves standing on a vibrating platform for short sessions, which may improve muscle function and glucose control without needing exercise.
Ankara, ÇankayaAges 18 years+ - NCT07006272Recruiting
Closed-loop pump vs islet transplant for unstable type 1 diabetes
This study compares two advanced treatments for type 1 diabetes that is hard to control: a closed-loop insulin pump system (which automatically adjusts insulin) versus islet cell transplantation (which replaces the cells that make insulin). It is for people whose blood sugar stays very unstable despite using the best current therapies.
Lyon, Auvergne-Rhône-AlpesAges 18 years+ - NCT07007676Recruiting
Continuous glucose monitor for older adults with type 2 diabetes
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Shenzhen, GuandongAges 60 years+ - NCT07018180Recruiting
Patch to help keep your CGM sensor on
This trial tests a special patch that helps keep continuous glucose monitor (CGM) sensors in place longer. It is for people with diabetes who have trouble keeping their sensor on and have high blood sugar levels.
BronAges 6 years+ - NCT07021222Recruiting
Preventing foot sores in diabetes
This study looks at ways to prevent foot sores in people with type 2 diabetes. It enrolls two groups: those at risk but without past sores, and those whose sores have healed for at least 6 months.
Bologna, BOAges 18–75 - NCT07021456Recruiting
How diet education affects eating disorder risk in type 1 diabetes
This study looks at how learning about counting carbs and adjusting insulin (called Functional Insulin Therapy) might impact eating habits and the risk of eating disorders in adults with type 1 diabetes.
GrenobleAges 18 years+ - NCT07023172Recruiting
Study of Proline Plus Empagliflozin for Type 2 Diabetes
This study is testing a new medication called Proline Plus Empagliflozin to see how well it works for people with type 2 diabetes. It is for people who are starting this medication for the first time.
Xinyang, HenanAges 18 years+ - NCT07029009RecruitingPhase 2
Liraglutide for MODY diabetes treatment study
This trial tests whether liraglutide, a once-daily injection, helps manage blood sugar in people with MODY diabetes. It's for those with high A1c levels and no prior use of similar drugs or certain health conditions.
Cincinnati, OhioAges 10 years+ - NCT07032688RecruitingPhase 1
Study of SHR-3167 for type 2 diabetes
This trial tests an experimental drug called SHR-3167 in people with type 2 diabetes. The goal is to see how the drug works in the body and how it affects blood sugar. It may be an option for adults who have had diabetes for at least 6 months.
Chengdu, SichuanAges 18–59 - NCT07039396Recruiting
NeoThelium FT for diabetic foot ulcers
This trial tests a new treatment called NeoThelium FT for diabetic foot ulcers. It aims to see if the treatment is safe and helps heal the ulcer. You may join if you have a diabetic foot ulcer that is not infected.
Alexandria, LouisianaAges 18 years+ - NCT07039617Recruiting
Testing a new insulin delivery algorithm at home for type 1 diabetes
This study compares a new automated insulin delivery algorithm (AIDANET) in two modes: fully closed-loop (no user input needed) versus hybrid closed-loop (user still gives some insulin for meals). It tests how well the algorithm works in real-life settings for adults with type 1 diabetes.
Charlottesville, VirginiaAges 18 years+ - NCT07040488Recruiting
Infrared camera study for diabetic foot in Guadeloupe
This study uses a special infrared camera to measure heat patterns in the feet of people with diabetes in Guadeloupe. The goal is to see if this painless method can help detect or monitor foot problems, which may prevent ulcers.
Pointe-à-PitreAges 18 years+ - NCT07041268RecruitingPhase 2
Rituximab for recent type 1 diabetes in teens
This trial tests if repeated infusions of rituximab (a drug that calms the immune system) can help preserve insulin production in adolescents newly diagnosed with type 1 diabetes. It is for teens in Russia who started diabetes treatment within the last 4 months.
MoscowAges 12–18
Hear when a new Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetic?
- Yes. Clin2 currently lists 2,208 recruiting diabetic studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetic trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetic trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.